Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human... see more

TSXV:CZO - Post Discussion

Ceapro Inc > How many ways could CZO change the game?
View:
Post by prophetoffactz on Jan 04, 2024 11:10am

How many ways could CZO change the game?

Inhalable yeast beta glucan...
that is swallowable by macrophages and can thereby hijack macrophages using macrophages as a second delivery system in the body...
PGX-YBG had 5X more binding capacity to the dectin-1 receptor on macrophages...
PGX-YBG can set a new standard for purity...

PGX-YBG can be impregnated with other bioactives...

By hijacking macrophages PGX could significantly improve delivery as demonstrated by the blowout CoQ10 bioavailaiblity results.

 

CZO news release: 

Yeast Beta Glucan (YBG) - Potential Inhalo-Therapeutic

  • Following the announcement of encouraging results made at two major international conferences earlier this year demonstrating that PGX-YBG is respirable and able to safely and reliably reprogram macrophages in the lungs in pre-clinical mouse models, additional research at McMaster University clearly showed that PGX-YBG gets into the macrophage cell. This important finding further supports the potential of YBG to act as a stand-alone and/or a carrier for other bioactives when transported by macrophages cells.
Comment by Tencents on Jan 04, 2024 12:00pm
There are in the region of 150000 known nanoparticules carriers, probably as many message carriers and a host of other carriers on the horizon or in use this is a very competitive and costly space to play in 
Comment by prophetoffactz on Jan 04, 2024 12:57pm
"Mr. Regnier added, “This is an exciting time in the Company’s history with the potential to generate growing value in the near and long term. I look forward to completing the development of technologies such as PGX, that continue to demonstrate its ability to successfully generate novel bioactive delivery systems at a quality that no other known technologies have been able to generate." ...more  
Comment by Tencents on Jan 04, 2024 2:00pm
The challenge will be that bio activity has been in scientific discovery since 1962  now 60 years later there is a magnitude of technologies delivering solutions in this area -all obviously staking their claims The reality probably is it's now a commodity environment, over supplied and very difficult to establish differentiation 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities